The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> October 31, 2024

Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)

Doroudian, Ahmad
Ahmad Doroudian, Ph.D., is Chief Executive Officer and Director of BetterLife Pharma Inc. Dr. Doroudian is an accomplished executive with over 25 years’ experience in management and development of private and publicly traded pharmaceutical companies, including M&A, multiple IPOs, and integration of pharmaceutical operations (Whitehall Robbins, Rhone Poulenc, Boehringer, Aventis). From 2009 to February 2014 Dr. Doroudian was the Founder, CEO and Director of Merus Labs Inc., a publicly listed specialty pharmaceutical company. From 2003 to 2009 he was involved in early stage financing of private and publicly listed companies. From 1994 to 2002 Dr. Doroudian was the Founder and CEO of PanGeo (Pharmex Industries). From 1990 to 1996 he was manager of operations at Novapharm (Teva), in charge of management of manufacturing, supply chain and process development facilities in Vancouver, British Columbia. Dr. Doroudian holds an M.Sc. in Pharmaceutics and a Ph.D. in Biopharmaceutics from the University of British Columbia. Profile
Word count: 1,817

TWST: Let’s start with a brief history of the company, including some major milestones.

Dr. Doroudian: Well, with the current lead product,

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
Interview with the Co-CEO and the CAO: Planet 13 Holdings Inc. (OTCMKTS:PLNH)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy